Title: Temperature dependent polymorphism of pyrazinamide: An in situ Raman and DFT study
| dc.contributor.author | Poornima Sharma | |
| dc.contributor.author | Rajib Nandi | |
| dc.contributor.author | Debraj Gangopadhyay | |
| dc.contributor.author | Anurag Singh | |
| dc.contributor.author | Ranjan K. Singh | |
| dc.date.accessioned | 2026-02-07T08:47:49Z | |
| dc.date.issued | 2018 | |
| dc.description.abstract | The α and γ polymorphs of drug pyrazinamide have been detected with the help of temperature dependent Raman spectroscopic technique. Pyrazinamide is a very useful drug used for the treatment of tuberculosis (TB) and plays a significant role in destroying the dormant tubercle bacilli which are not destroyed by other common TB drugs. Temperature dependent Raman spectra suggest polymorphic phase change from α → γ form of pyrazinamide between 145 and 146 °C. In situ Raman spectra of pyrazinamide between 145 and 146 °C show the conversion of α → γ form by the shift in C[dbnd]O stretching vibration accompanied by several other changes. The phase change is characterized by the breaking of two linear N[sbnd]H ⋯ O type hydrogen bonds associated with C[dbnd]O stretching vibration in α dimer and formation of one linear N[sbnd]H ⋯ N type hydrogen bond along with a weak intramolecular C[sbnd]H ⋯ O type hydrogen bond in the γ dimer. © 2017 | |
| dc.identifier.doi | 10.1016/j.saa.2017.09.016 | |
| dc.identifier.issn | 13861425 | |
| dc.identifier.uri | https://doi.org/10.1016/j.saa.2017.09.016 | |
| dc.identifier.uri | https://dl.bhu.ac.in/bhuir/handle/123456789/32577 | |
| dc.publisher | Elsevier B.V. | |
| dc.subject | DFT | |
| dc.subject | Hydrogen bonding | |
| dc.subject | Pyrazinamide | |
| dc.subject | Raman spectroscopy | |
| dc.subject | Tuberculosis | |
| dc.title | Temperature dependent polymorphism of pyrazinamide: An in situ Raman and DFT study | |
| dc.type | Publication | |
| dspace.entity.type | Article |
